STA opening new transition metal catalysis center at API site
The new Changzhou, China-based site adds transition metal catalyst-screening technology to STA’s small molecule process development and manufacturing platform.
The new Changzhou, China-based site adds transition metal catalyst-screening technology to STA’s small molecule process development and manufacturing platform.
“Bring Your Own Device” (BYOD) in clinical trials will be a “critical component” of future research says Bracket CEO following the company’s acquisition of mProve Health.
Parexel has partnered with Microsoft to advance patient-centric technologies and help deliver on the promise of personalized medicine following a need for efficiency and innovation in drug development.
CPHI WORLDWIDE 2017
Drug firms need excipients suited to continuous manufacturing according to Dow, which says a better understanding of how products perform when used in round-the-clock production is required.
Sartorius Stedim Biotech (SSB) has cut its full year guidance, citing the negative impact of hurricane Maria, customer destocking and ongoing issues with a cell culture media supplier.
Correction
US FDA inspectors have raised concerns about Akorn Inc’s manufacturing facility on Grand Avenue in Decatur, Illinois in a Form 483 made public this month.
Evertogen Life Sciences Limited should recall drugs made at its facility in Mahabubnagar, India according to the MHRA, which identified critical quality and data integrity problems during an audit in August.
Australian regulators have confirmed that Asymchem Laboratories Tianjin Co Ltd’s API plant in Dunhua, China is up to code.